Innovating Works

OXPROTECT

Desconocido
TRENDO: Translational Research on Endometriosis OXPROTECT GMBH participó en un H2020: H2020-MSCA-RISE-2020 Endometriosis is a sever disease affecting 10% of reproductive age women, characterized by the presence of endometrial-like tissue outside o...
2020-10-05 - 2025-07-31 | Financiado
REFINE: Regulatory Science Framework for Nano bio material based Medical Products and Devices OXPROTECT GMBH participó en un H2020: H2020-NMBP-2016-2017 REFINE proposes a Regulatory Science Framework for the risk-benefit assessment of medical products and medical devices that are based on nan...
2017-11-29 - 2022-02-28 | Financiado
EUNCL: European Nanomedicine Characterization Laboratory OXPROTECT GMBH participó en un H2020: H2020-INFRAIA-2014-2015 In order to accelerate the development of the nanomedicine business in Europe, EU-NCL interconnects 8 European and 1 American key reference...
2015-06-26 - 2019-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.